Serology COVID-19
Venous blood/serum/plasma Antibody screen for IgM/IgG (SARS CoV2)

FDA Authorized (EUA)

BioTest COVID-19 downloads

IgM/IgG antibody rapid serology test cassette.

Black-PDF-download.png
Black-PDF-download.png
pdf-download-icon.jpg

Available in Limited Quantities to CLIA registered facilities. For Professional Use Only.

Have Questions?

(877) 868-9967 or Info@SmartScreens.net

GET FREE
Donor Packages
When you order, make sure to ask for the FREE Donor packages and FREE spare testing supplies.
​

​What is included:

​

  • FDA mandated Fact Sheet

  • CDC/FDA helpful links

  • Antibody testing information

  • Simple to use result form

  • COVID-19 safety information

blue-PDF-download.png
GET FREE
Spare Supplies
On your first order, you will receive a complimentary counter sign that lets patients know you offer antibody testing, a digital timer to help ensure results are read at the correct time, individually-wrapped spare sterile pipettes and an extra bottle of buffer solution to speed up testing.
​
blue-PDF-download.png

Have Questions?

(877) 868-9967 or Info@SmartScreens.net

REQUEST MORE INFORMATION (QUOTE FORM)

Contact your Smart Screens COVID specialist for pricing or complete the form below for quotes in less than 20-minutes.

Company Information

Please complete the form below.

Testing Volume

Enter estimated order size for quote.

Product ID

SS-COV-Serology

Description

COVID-19 IgM/IgG Rapid Blood Antibody Test

Packaging

25 ea/bx

Product ID

SS-COV-Saliva

Description

COVID-19 IgM/IgG Rapid Saliva Antibody Test

Packaging

25 ea/bx

IMPORTANT COVID-19 ANTIBODY TEST INFORMATION

​

This test has been authorized by FDA under an EUA for use by authorized laboratories. 

​

This test has not been FDA cleared or approved.

​

This test has been authorized only for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens.

​

This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

​

Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.

​

This product is intended for professional use and not for home use.

​

Not for the screening of donated blood.

 
Â